Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Receivables - Other (2023)

Updated

Impact Biomedical's Receivables - Other came in at $128,000 for Q4 2023.

Analysis

Impact Biomedical (IBO) Receivables - Other (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 128,000.00
Jun 30, 2023 94,000.00
API Access

Impact Biomedical Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=IBO&period=max&api_key=YOUR_API_KEY